Prophylactic Human Vaccine Market - Global Outlook and Forecast 2021-2027
Report Code: KNJ940249 No. of Pages: 108 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Prophylactic Human Vaccine in global, including the following market information:
Global Prophylactic Human Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Prophylactic Human Vaccine Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Prophylactic Human Vaccine companies in 2020 (%)
The global Prophylactic Human Vaccine market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prophylactic Human Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prophylactic Human Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Prophylactic Human Vaccine Market Segment Percentages, By Type, 2020 (%)
Inactivated Vaccine
Attenuated Vaccine
Others
Global Prophylactic Human Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Prophylactic Human Vaccine Market Segment Percentages, By Application, 2020 (%)
Hospital
Scientific Research
Others
Global Prophylactic Human Vaccine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Prophylactic Human Vaccine Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prophylactic Human Vaccine revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Prophylactic Human Vaccine revenues share in global market, 2020 (%)
Key companies Prophylactic Human Vaccine sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Prophylactic Human Vaccine sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Biovac
McKesson Medical
Merck
Merial
Zoetis
Sanofi
1 Introduction to Research & Analysis Reports
1.1 Prophylactic Human Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prophylactic Human Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prophylactic Human Vaccine Overall Market Size
2.1 Global Prophylactic Human Vaccine Market Size: 2021 VS 2027
2.2 Global Prophylactic Human Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Prophylactic Human Vaccine Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Prophylactic Human Vaccine Players in Global Market
3.2 Top Global Prophylactic Human Vaccine Companies Ranked by Revenue
3.3 Global Prophylactic Human Vaccine Revenue by Companies
3.4 Global Prophylactic Human Vaccine Sales by Companies
3.5 Global Prophylactic Human Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Prophylactic Human Vaccine Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Prophylactic Human Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prophylactic Human Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Prophylactic Human Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Prophylactic Human Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Prophylactic Human Vaccine Market Size Markets, 2021 & 2027
4.1.2 Inactivated Vaccine
4.1.3 Attenuated Vaccine
4.1.4 Others
4.2 By Type - Global Prophylactic Human Vaccine Revenue & Forecasts
4.2.1 By Type - Global Prophylactic Human Vaccine Revenue, 2016-2021
4.2.2 By Type - Global Prophylactic Human Vaccine Revenue, 2022-2027
4.2.3 By Type - Global Prophylactic Human Vaccine Revenue Market Share, 2016-2027
4.3 By Type - Global Prophylactic Human Vaccine Sales & Forecasts
4.3.1 By Type - Global Prophylactic Human Vaccine Sales, 2016-2021
4.3.2 By Type - Global Prophylactic Human Vaccine Sales, 2022-2027
4.3.3 By Type - Global Prophylactic Human Vaccine Sales Market Share, 2016-2027
4.4 By Type - Global Prophylactic Human Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prophylactic Human Vaccine Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Scientific Research
5.1.4 Others
5.2 By Application - Global Prophylactic Human Vaccine Revenue & Forecasts
5.2.1 By Application - Global Prophylactic Human Vaccine Revenue, 2016-2021
5.2.2 By Application - Global Prophylactic Human Vaccine Revenue, 2022-2027
5.2.3 By Application - Global Prophylactic Human Vaccine Revenue Market Share, 2016-2027
5.3 By Application - Global Prophylactic Human Vaccine Sales & Forecasts
5.3.1 By Application - Global Prophylactic Human Vaccine Sales, 2016-2021
5.3.2 By Application - Global Prophylactic Human Vaccine Sales, 2022-2027
5.3.3 By Application - Global Prophylactic Human Vaccine Sales Market Share, 2016-2027
5.4 By Application - Global Prophylactic Human Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Prophylactic Human Vaccine Market Size, 2021 & 2027
6.2 By Region - Global Prophylactic Human Vaccine Revenue & Forecasts
6.2.1 By Region - Global Prophylactic Human Vaccine Revenue, 2016-2021
6.2.2 By Region - Global Prophylactic Human Vaccine Revenue, 2022-2027
6.2.3 By Region - Global Prophylactic Human Vaccine Revenue Market Share, 2016-2027
6.3 By Region - Global Prophylactic Human Vaccine Sales & Forecasts
6.3.1 By Region - Global Prophylactic Human Vaccine Sales, 2016-2021
6.3.2 By Region - Global Prophylactic Human Vaccine Sales, 2022-2027
6.3.3 By Region - Global Prophylactic Human Vaccine Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Prophylactic Human Vaccine Revenue, 2016-2027
6.4.2 By Country - North America Prophylactic Human Vaccine Sales, 2016-2027
6.4.3 US Prophylactic Human Vaccine Market Size, 2016-2027
6.4.4 Canada Prophylactic Human Vaccine Market Size, 2016-2027
6.4.5 Mexico Prophylactic Human Vaccine Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Prophylactic Human Vaccine Revenue, 2016-2027
6.5.2 By Country - Europe Prophylactic Human Vaccine Sales, 2016-2027
6.5.3 Germany Prophylactic Human Vaccine Market Size, 2016-2027
6.5.4 France Prophylactic Human Vaccine Market Size, 2016-2027
6.5.5 U.K. Prophylactic Human Vaccine Market Size, 2016-2027
6.5.6 Italy Prophylactic Human Vaccine Market Size, 2016-2027
6.5.7 Russia Prophylactic Human Vaccine Market Size, 2016-2027
6.5.8 Nordic Countries Prophylactic Human Vaccine Market Size, 2016-2027
6.5.9 Benelux Prophylactic Human Vaccine Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Prophylactic Human Vaccine Revenue, 2016-2027
6.6.2 By Region - Asia Prophylactic Human Vaccine Sales, 2016-2027
6.6.3 China Prophylactic Human Vaccine Market Size, 2016-2027
6.6.4 Japan Prophylactic Human Vaccine Market Size, 2016-2027
6.6.5 South Korea Prophylactic Human Vaccine Market Size, 2016-2027
6.6.6 Southeast Asia Prophylactic Human Vaccine Market Size, 2016-2027
6.6.7 India Prophylactic Human Vaccine Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Prophylactic Human Vaccine Revenue, 2016-2027
6.7.2 By Country - South America Prophylactic Human Vaccine Sales, 2016-2027
6.7.3 Brazil Prophylactic Human Vaccine Market Size, 2016-2027
6.7.4 Argentina Prophylactic Human Vaccine Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Prophylactic Human Vaccine Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Prophylactic Human Vaccine Sales, 2016-2027
6.8.3 Turkey Prophylactic Human Vaccine Market Size, 2016-2027
6.8.4 Israel Prophylactic Human Vaccine Market Size, 2016-2027
6.8.5 Saudi Arabia Prophylactic Human Vaccine Market Size, 2016-2027
6.8.6 UAE Prophylactic Human Vaccine Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Corporate Summary
7.1.2 GSK Business Overview
7.1.3 GSK Prophylactic Human Vaccine Major Product Offerings
7.1.4 GSK Prophylactic Human Vaccine Sales and Revenue in Global (2016-2021)
7.1.5 GSK Key News
7.2 Biovac
7.2.1 Biovac Corporate Summary
7.2.2 Biovac Business Overview
7.2.3 Biovac Prophylactic Human Vaccine Major Product Offerings
7.2.4 Biovac Prophylactic Human Vaccine Sales and Revenue in Global (2016-2021)
7.2.5 Biovac Key News
7.3 McKesson Medical
7.3.1 McKesson Medical Corporate Summary
7.3.2 McKesson Medical Business Overview
7.3.3 McKesson Medical Prophylactic Human Vaccine Major Product Offerings
7.3.4 McKesson Medical Prophylactic Human Vaccine Sales and Revenue in Global (2016-2021)
7.3.5 McKesson Medical Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck Prophylactic Human Vaccine Major Product Offerings
7.4.4 Merck Prophylactic Human Vaccine Sales and Revenue in Global (2016-2021)
7.4.5 Merck Key News
7.5 Merial
7.5.1 Merial Corporate Summary
7.5.2 Merial Business Overview
7.5.3 Merial Prophylactic Human Vaccine Major Product Offerings
7.5.4 Merial Prophylactic Human Vaccine Sales and Revenue in Global (2016-2021)
7.5.5 Merial Key News
7.6 Zoetis
7.6.1 Zoetis Corporate Summary
7.6.2 Zoetis Business Overview
7.6.3 Zoetis Prophylactic Human Vaccine Major Product Offerings
7.6.4 Zoetis Prophylactic Human Vaccine Sales and Revenue in Global (2016-2021)
7.6.5 Zoetis Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Prophylactic Human Vaccine Major Product Offerings
7.4.4 Sanofi Prophylactic Human Vaccine Sales and Revenue in Global (2016-2021)
7.7.5 Sanofi Key News
8 Global Prophylactic Human Vaccine Production Capacity, Analysis
8.1 Global Prophylactic Human Vaccine Production Capacity, 2016-2027
8.2 Prophylactic Human Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Prophylactic Human Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prophylactic Human Vaccine Supply Chain Analysis
10.1 Prophylactic Human Vaccine Industry Value Chain
10.2 Prophylactic Human Vaccine Upstream Market
10.3 Prophylactic Human Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prophylactic Human Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com